Top

Neurogenetics

Published in:

01-11-2007 | Letter to the Editors

An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion

Authors: Christian Beetz, Anders O. H. Nygren, Thomas Deufel, Evan Reid

Published in: Neurogenetics | Issue 4/2007

Excerpt

Sirs, …

Available only for authorised users

Reid E (1999) The hereditary spastic paraplegias. J Neurol 246:995–1003CrossRefPubMed

Fink JK (2002) Hereditary spastic paraplegia: the pace quickens. Ann Neurol 51:669–672CrossRefPubMed

Elliot JL (2004) Beginning to understand hereditary spastic paraplegia atlastin. Arch Neurol 61:1842–1843CrossRef

Penny EB, McCabe BD (2005) All neuropathies great and small. J Clin Invest 115:2968–2971CrossRefPubMed

Beetz C, Nygren AO, Schickel J, Auer-Grumbach M, Burk K, Heide G, Kassubek J, Klimpe S, Klopstock T, Kreuz F, Otto S, Schule R, Schols L, Sperfeld AD, Witte OW, Deufel T (2006) High frequency of partial SPAST deletions in autosomal dominant hereditary spastic paraplegia. Neurology 67:1926–1930CrossRefPubMed

Namekawa M, Ribai P, Nelson I, Forlani S, Fellmann F, Goizet C, Depienne C, Stevanin G, Ruberg M, Durr A, Brice A (2006) SPG3A is the most frequent cause of hereditary spastic paraplegia with onset before age 10 years. Neurology 66:112–114CrossRefPubMed

Zhu PP, Soderblom C, Tao-Cheng JH, Stadler J, Blackstone C (2006) SPG3A protein atlastin-1 is enriched in growth cones and promotes axon elongation during neuronal development. Hum Mol Genet 15:1343–1353CrossRefPubMed

Meijer IA, Dion P, Laurent S, Dupre N, Brais B, Levert A, Puymirat J, Rioux MF, Sylvain M, Zhu PP, Soderblom C, Stadler J, Blackstone C, Rouleau GA (2007) Characterization of a novel SPG3A deletion in a French-Canadian family. Ann Neurol 61:599–603CrossRefPubMed

Title: An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion
Authors: Christian Beetz
Anders O. H. Nygren
Thomas Deufel
Evan Reid
Publication date: 01-11-2007
Publisher: Springer-Verlag
Published in: Neurogenetics / Issue 4/2007
Print ISSN: 1364-6745
Electronic ISSN: 1364-6753
DOI: https://doi.org/10.1007/s10048-007-0099-8

Keynote webinar | Spotlight on medication adherence

Springer Medicine

An SPG3A whole gene deletion neither co-segregates with disease nor modifies phenotype in a hereditary spastic paraplegia family with a pathogenic SPG4 deletion

Excerpt

Keynote webinar | Spotlight on medication adherence

Springer Medicine

Excerpt

Please log in to get access to this content

Other articles of this Issue 4/2007

SPG11: a consistent clinical phenotype in a family with homozygous Spatacsin truncating mutation

CCM3 interacts with CCM2 indicating common pathogenesis for cerebral cavernous malformations

Robust quantification of the SMN gene copy number by real-time TaqMan PCR

Refinement of the SPG15 candidate interval and phenotypic heterogeneity in three large Arab families

Evidence of shared risk for Alzheimer’s disease and Parkinson’s disease using family history

Functional, histopathologic and natural history study of neuropathy associated with EGR2 mutations